Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

The FDA has approved one GLP-1 pill, Rybelsus, but only for people with type 2 diabetes, Reshmi Srinath, MD, an associate professor of medicine and director of the Weight and Metabolism Management ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

Rybelsus is a pill form version of semaglutide – an FDA approved prescribed medication to manage blood sugar levels in patients with type 2 diabetes. Another effect that Rybelsus has is that it can ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

The FDA approval last Friday of Novo Nordisk’s Rybelsus as the first orally-active GLP-1 agonist is only the first challenge facing the company as it pursues its blockbuster sales targets for ...

Many pills and treatments are available for weight ... Two examples include metformin and Rybelsus® (semaglutide). Some healthcare providers prescribe these off-label for weight loss, which ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...

GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to blockbuster drug semaglutide, which it sells as Ozempic, Wegovy and Rybelsus.

Ozempic's ads were 57% more effective in driving consumer engagement on streaming TV than on linear TV during Q3.